FUJIFILM has been actively pursuing reinforcement of business in the fields of biomedical and healthcare. By leveraging FUJIFILM Group’s collective bio-related technologies, including FUJIFILM Wako Pure Chemical and FUJIFILM Irvine Scientific, FUJIFILM continues to accelerate the growth and provide a broad product portfolio in bio-medical through synergies and collaborations.

FUJIFILM Wako Pure Chemical (FFWK) is a world-leading supplier of high purity chemicals and reagents based in Japan. FFWK has broad product lines, from various raw materials to QC/QA testing products, in its Laboratory chemicals to precisely meet various needs in all fields of study. FFWK also maintains a cell culture media production facility that follows the cGMP principle and underclass 100-100,000 management with humidity/temperature control.

With over 45 years of industry experience, FUJIFILM Irvine Scientific (FISI) is a worldwide leader in the innovation and manufacture of cell culture media. FISI offers a diverse portfolio of advanced cell culture media solutions including high-performance, proprietary chemically-defined media, rapid media screening, and optimization services, and close technical support designed to shorten development timelines and reduce costs. FISI adheres to both ISO and FDA regulations and currently operates dual cGMP manufacturing facilities in California, the USA, and Tokyo, Japan, with a third site due to be commissioned in 2021 in Tilburg, Netherlands.

For more information, please visit: http://ffwk.fujifilm.co.jp/en/index.html or http://www.irvinesci.com/

Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development, and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.

For more information, please visit: kr.vwr.com or avantorsciences.com

Pall Corporation provides critical filtration, separation, and purification solutions to meet the demanding needs of a broad spectrum of life sciences and industrial customers around the globe. Across 80 locations and 10,000 people worldwide, we are unified by a singular drive: to solve our customers' biggest fluid management challenges. And in doing so advance health, safety, and environmentally responsible technologies. Together, our Life Sciences and Industrial teams serve a diverse range of customers including biotechnology, pharmaceutical, medical, food and beverage, laboratory, microelectronics, aerospace, fuels, petrochemical, chemical, automotive and power generation industries. Our industry-leading technologies and solutions are at work in countless applications, protecting critical operating assets, improving product quality, safeguarding the health, and minimizing emissions and waste

For more info, please check: https://www.pall.com/en/biotech.html

West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability, and safety of the world's pharmaceutical drug supply.  West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia, and Australia. West's 2019 net sales of $1.84 billion reflect the daily use of approximately 100 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world.

https://www.westpharma.com/

GenScript is a global biotechnology group. GenScript’s businesses encompass four major categories based on its leading gene synthesis technology, including operation as a Life Science CRO, enzyme and synthetic biology products, biologics development and manufacturing, as well as cell therapy.

Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific. Today, over 300,000 customers from over 160 countries and regions around the world have used GenScript’s premier, convenient, and reliable products and services.

GenScript currently has more than 3000 employees globally, 33% of whom hold master’s and/or Ph.D. degrees. In addition, GenScript has a number of leading commercial technologies developed in the fields of synthetic biology, immunotherapy, antibody design, chemical synthesis and bioinformatics, including more than 70 patents and over 200 patent applications. As of January 2019, GenScript's products and services have been cited by 36,500 scientific papers worldwide.

GenScript is committed to striving towards its vision of being the most reliable biotech company in the world to make humans and nature healthier through biotechnology.

For more information, visit www.genscript.com

Principal Contact Name: Cassie Yap/ Boon Hwa Tay
Email Address: cassie.yap@genscript.com / boonwha.tay@genscript.com
Position: Marketing Supervisor / Marketing Specialist

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically.

Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of “turning science into solutions”
The products we can offer including:

- Filtration technology
- Fermentation technology including single or multi-use bioreactor
- Purification technology including tangential flow, membrane chromatography
- Fluid management technology including mixing, container, freeze-thaw system
- Microbiological control system, including sterility testing
- Biotech service including training, extractable and leachable test

Sartonets Taiwan Ltd. were established in July, 2007 to integrate Sartorius Stedim Biotech high-end technologies into indigenous needs and provide outstanding sales service to Biotech industries in Taiwan. With a loyal companion to our clients from research, development, scale-up to product launch, we already become one of the pillars of single-use technologies and equipment supplier in Biotech industries in Taiwan.

We offer total solutions, technical supporting and after sales service covering:
- Filtration
- Fermentation
- Purification
- Fluid management
- Quality control and service
- Contamination stop system like isolator, RAB
- Process machine like API formulation dispensing
- Utility system like CIP system, water system

Websitehttps://www.sartorius.com/en

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guides us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe.

The drug research and development process is highly complex, yet essential for delivering safe and effective therapies to patients. Even though the process is well defined, drug development programs are fundamentally different for each product.

Website: https://www.criver.com

With Our Technology, You Can See the Future Differently
As part of the Danaher family of global life science and technology innovators, SCIEX has led the field of mass spectrometry for more than 50 years. From the moment we launched the first ever commercially successful triple quad in 1981, we have continued to develop groundbreaking technologies and solutions that have influenced life-changing research and clinical diagnostic outcomes.

We Innovate with Purpose, to Meet the Evolving Needs of the Laboratory
Big challenges face our world today, driving scientific research, routine testing and ultimately the needs of the lab. In partnership with our customers, we are at the forefront of anticipating these needs and are devoted to pioneering solutions to surpass them. We help you to discover answers for science and knowledge for life, which is why SCIEX is a trusted partner to thousands of scientific experts worldwide.

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

For more information, please visit www.thermofisher.com.

Merck, a life science leader, is a business of Merck KGaA, Darmstadt, Germany. Our comprehensive portfolio supports customers during all stages of the drug manufacturing process. With our broad range of products, applications and services including single-use manufacturing, filtration, chromatography and purification, virus reduction, pharma and biopharma raw materials, drug delivery compounds, and engineering and validation services we are committed to best support your goals of intensified, connected or continuous bioprocessing. Our industry expertise and regulatory know-how help you get to clinic faster, allowing you to focus on what matters most — delivering safe, effective therapies sooner to the patients that need them most.

For more information, please visit:  MerckMillipore.com/BioContinuum

Thermo Fisher Scientific’s Patheon and Fisher Clinical Services brands have come together to provide industry-leading pharma services solutions for drug development, clinical trial logistics and commercial manufacturing to customers of all sizes. With more than 40 locations around the world, the company can provide integrated, end-to-end capabilities across all phases of development, including API, biologics, formulation, clinical trials solutions, logistics services and commercial manufacturing.

We give all sizes of pharma and biotech companies, including the very smallest, instant access to a fully integrated global network of facilities across North America, Europe, Asia and Australia.

Our global leadership is built on a reputation for scientific and technical excellence. This includes specialized capabilities for highly potent and controlled substances, aseptic filling and lyophilization, complex formulations, solubility enhancement and difficult-to-manufacture APIs. We also offer integrated services for drug development that aligns development of drug substance and drug product in a coordinated drive toward proof of concept that can reduce development timelines.

We have more than 12,000 scientific and professional staff and over 40 years of experience. As a leading global CDMO, we deliver unrivaled quality, reliability and compliance. Together with more than 400 clients, we’re rapidly turning pharmaceutical possibilities into realities.

Website: https://patheon.com

en_USEnglish
Open chat
Come chat with us!
Hello! How can I help you?

Kindly fill in the form below to receive the handbook via email

    Products of Interest*
    Blood & Plasma ProductsAntibody TherapeuticsCell TherapyGene TherapyProtein TherapeuticsViral VaccinesImmunotherapeuticsOther BiologicsNon-biologicsMedical DeviceNone of the above

    Subscribe to our mailing list


    https://www.imapac.com/en/business_conferences/biologics-manufacturing-korea/

    https://www.imapac.com/en/business_conferences/korea-bioprocessing-excellence-awards/#popup2